Stago EdVantage Virtual University is an educational platform that demystifies hemostasis testing with on-demand webinars and a virtual exhibit hall that explore basic and complex concepts, making them accessible to novices as well as experienced users. In an ever evolving landscape of research and publication, it can be challenging to stay current. By listening to industry key opinion leaders and Stago experts, you can be assured of staying informed of the latest best practices.
Benefits of the Stago EdVantage Virtual University comprehensive online webcast library include being able to access programs 24/7, participate in complete trainings on-the-go with our mobile compatible platform, train at your leisure with stop and start capability, and receive instantaneous training certificates upon completion. With Stago EdVantage Virtual University, you can maintain education and accreditation requirements at no cost, on demand and on your schedule, so you can participate more frequently and implement new tools more rapidly.
Diagnostica Stago has long placed a high priority on hemostasis education. We are glad you have chosen to attend Stago EdVantage Virtual University.
OCT 13 2016 6:00 AM PT
Leonardo R. Brandao, MD, Msc
Associate Professor of Pediatrics, University of Toronto, Hemostasis and Thrombosis Service, The Hospital for Sick Children
JUN 10 2016 8:00 AM PT
Oksana Volod, MD
Director, Coagulation Consultative Service Director, Pathology and Laboratory Medicine Residency Program, Associate Professor, Cedars Sinai Medical Center
MAY 23 2016 8:00 AM PT
James B Groce III, Pharm. D, CACP
Professor, Department of Pharmacy Practice, Campbell University School of Pharmacy, Clinical Assistant Professor of Medicine, University of North Carolina School of Medicine, Clinical Pharmacy Specialist-Anticoagulation, Moses H. Cone Memorial Hospital
MAY 2 2016 8:00 AM PT
Jeremy Vandiver, Pharm D, BCPS
Clinical Assistant Professor of Pharmacy Practice, University of Wyoming School of Pharmacy
MAY 29 2015 8:00 AM PT
Donna D Castellone, MS, MT(ASCP) SH
Supervisor, Special Coagulation and Hematology, New York Presbyterian- Columbia
APR 24 2014 8:00 AM PT
Lynn Boshkov, MD
Prof. of Pathology, Medicine & Pediatrics Director of Hemostasis & Thrombosis, Oregon Health & Science University (OHSU)
NOV 15 2013 8:00 AM PT
Gabrielle Pearl, MT(ASCP)
Manager, Hematology & Flow Cytometry Department of Pathology & Laboratory Medicine, Children’s Hospital Colorado
MAY 20 2013 8:00 AM PT
Neil S. Harris, MD
Associate Professor, College of Medicine Department of Pathology, Immunology and Laboratory Medicine, University of Florida
JUN 15 2012 8:00 AM PT
Richard Marlar, PhD
Professor of Pathology Chief, Clinical Pathology, VA Medical Center, Department of Pathology, University of Oklahoma Health Sciences Center
APR 2 2012 8:00 AM PT
Suman W Rathbun, MD, MS, FACP
Professor Department of Medicine, Adjunct Professor Department of Radiological Sciences, College of Medicine University of Oklahoma Health Sciences Center
The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here.
Keri is a Clinical Pharmacist in the Commercial and Specialty Pharmacy Division at Florida Blue where she primarily establishes and maintains medical coverage guidelines for specialty medications. Keri previously worked as an Assistant Professor in the Department of Pharmacy Practice at South University from 2010 to 2015. She coordinated and lectured in courses including Communications, Quality Improvement and Patient Safety, Professional Practice and Informatics, and Drug Information. She precepted residents and students in the Drug information center and established a clinical practice site for students in Internal Medicine at Southeast Georgia Regional Health System. Keri completed an ASHP accredited PGY1 residency at Shands Jacksonville and a PGY2 specialty residency in Drug Information at South University, with accompanying activities at Memorial University Medical Center, St. Joseph’s/Candler Hospital, and NorthStar Healthcare Consulting. Prior to attending pharmacy school at South University, Keri worked as a software consultant in informatics for Cerner Corporation from 2001 to 2005. Keri is an active member of GSHP and serves as the Southeast District Director coordinating district meetings in the Savannah and St. Simons area. She previously served as co-chair of the GSHP Education Committee from 2011 to 2014. Keri is also a member of ACCP, ASHP, AACP, the American Cancer Society Victory Board, Auxiliary of Hospice of the Golden Isles, and the Golden Isles UGA Alumni Association.
Dr. Boshkov specializes in coagulation abnormalities and testing, and blood transfusion, including support of Jehovah's Witness patients. She is the principal investigator in clinical trials to determine if the use of prestorage leukoreduced blood products modifies the outcome in cardiac surgery patients. Dr. Boshkov heads hemostasis and thrombosis at OHSU, and is the associate director of transfusion medicine. She is married with two sons, and is fluent in French.
Dr. Leonardo Brandao is a native Brazilian who obtained his medical degree at University of Sao Paulo (USP). After doing post-graduate training at the same institution, he pursued training in North America in Pediatrics (Emory University, Atlanta, Georgia), Pediatric Hematology/Oncology (St. Jude Children's Research Hospital, Memphis, Tennessee) and Pediatric Coagulation (Weill Cornell University, New York, New York). In brief, his North American training initially included a fellowship at St. Jude’s Children’s Research Hospital, where he was actively involved in studying clinical coagulation laboratory tools in children with acute lymphoid leukemia, as well as working in a gene therapy laboratory to study the expression of antithrombin by different cell lines. This was followed by training in pediatrics/coagulation (Emory University), where he developed and coordinated research projects on bleeding (pediatric bleeding score, platelet function defects). During his second fellowship training at Weill Cornell University, his research was solely focused on pediatric coagulation, in the management of both bleeding (new laboratory tools for phenotype definition in hemophilia) and thrombosis (the role of inherited thrombophilia in venous thrombosis) in children. He is currently a staff member with the Hemostasis and Thrombosis Service. This is Canada’s largest referral based-tertiary hospital. Because of its’ privileged position in the field of pediatric thrombosis, Sickkids® continues to be instrumental in the development of the field of pediatric thrombosis, by participating in several dose finding studies for several of the new anticoagulants in children, as well as other prospective clinical research studies (i.e. perfusion medicine, cardiology, pediatric thrombosis). Dr. Brandao is also actively involved in the field of coagulation in children with congenital heart defects, in the area of long-term thrombosis outcome (i.e. post-thrombotic syndrome), and in the subject of coagulation derangements in children with vascular anomalies.
Presently, I am both the Supervisor of Special Coagulation and the QA Manager for Specialty Testing at New York Presbyterian Hospital- Columbia. I also am an adjunct professor at SUNY Stony Brook, New York and a guest lecturer at Rutgers in New Jersey. I have given hundreds of lectures on coagulation throughout the world, and presented posters at many conferences. One of my passions is writing, and I have published over 100 articles and worked on 5 text books. I have 32 years of clinical laboratory experience and an additional 6 years working in industry with clinical trial experience. I am on the Editorial Board for Laboratory Medicine and Advance for Administrators of the Laboratory. Additionally, my involvement with ASCP has put me on the Workshop committee, Board of Registry and currently I serve as co-chair of the Editorial Board. I am also on the executive committee of NASCOLA (North American Specialized Coagulation Laboratories Association). I am a member of the CLSI guidelines committee: Hematology Area and worked on the CLSI Lupus Anticoagulant 2010-2014 and chair the CLSI Factor Assay document.
James B Groce Ill, PharmD, CACP, is Professor, Department of Pharmacy Practice at Campbell University School of Pharmacy. Dr. Groce also is Clinical Assistant Professor of Medicine at the University of North Carolina School of Medicine and Clinical Pharmacy Specialist-Anticoagulation at the Moses H. Cone Memorial Hospital in Greensboro, North Carolina, where he manages an anticoagulation clinic serving over 100 patients and supervises pharmacy practice and medicine residents training in anticoagulation management at this site. He served as principal investigator at Moses H. Cone Health System for DVT FREE, a national registry trial examining risk factors and prevalence of DW. Additionally, he was part of the II- member steering committee for this initiative. He represents pharmacy nationally on the Council for Leadership on Thrombosis Awareness and Management (CLOT Council) as its sole pharmacist member on this physician-based panel of National thought leaders and experts on thromboembolism as well as the Coalition Against DW in the same capacity. He was recently appointed to the Technical Advisory Panel of JCAHOINQF for creation of core measures for prevention and treatment of venous thromboembolism. Most recently, he was named Preceptor of the Year by the graduating classes of 2006 and 2007, Campbell University School of Pharmacy. Dr. Groce has been published and cited in peer-reviewed medical and pharmacy journals as well as textbooks of pharmacy. He has presented extensively regarding the interchange of Narrow Therapeutic Index Drugs and its impact with respect to efficacy and safety, and pharmacoeconmics; he gave testimony before the state Senate and House Subcommittees of the North Carolina Legislature examining this issue that resulted in Senate Bill 945 - The Prescription Refill Safety Act. He is certified by the National Certification Board of Anticoagulation Providers and currently is a sitting member of its Board of Directors.
Dr. Neil S. Harris is board-certified in anatomic and clinical pathology, as well as clinical chemistry through the American Board of Clinical Chemistry. He is currently the director of the core (chemistry/hematology) laboratory, in addition to being a clinical associate professor at the Department of Pathology, Immunology and Laboratory Medicine within the University of Florida's College of Medicine. Dr. Harris received his undergraduate and medical education at the University of Cape Town in South Africa. In the 1980s, his postgraduate training included a residency in clinical pathology (chemical pathology & immunology) in the Division of Pathology at the University of Cape Town. This was followed by a research fellowship in the Division of Hematology/Oncology and a fellowship in clinical chemistry at the Department of Laboratory Medicine at the Children's Hospital in Boston, Massachusetts. He obtained his USA credentials in pathology by completing his residency at Fletcher Allen Health Care in at the University of Vermont in Burlington.
L. Eleanor J. Herriman, M.D., M.B.A. is the Chief Medical Informatics Officer at Viewics. She is a physician executive with 20 years of varied healthcare industry experience. Before joining Viewics, Eleanor was a faculty member at Harvard Business School’s Institute for Strategy and Competitiveness. Prior career experience includes: market research and strategy services to the pathology and laboratory industries at G2 Intelligence, healthcare strategy consulting at Bain & Company, and multiple startup medical technology ventures. Dr. Herriman holds a Doctor of Medicine degree from Baylor College of Medicine and was awarded the Presidents Scholarship. Dr Herriman also holds a Masters in Business Administration from Harvard University Graduate School of Business Administration as a Baker Scholar and a Bachelors of Science in electrical engineering from Rice University with a minor in bioengineering.
Dr. Christopher Kabrhel is an attending physician at the Massachusetts General Hospital Department of Emergency Medicine. He graduated from John Hopkins University School of Medicine. He then completed his residency with Harvard Affiliated Emergency Medicine Residency Program (HAEMR) at Brigham and Women's Hospital and Massachusetts General Hospital. Dr. Kabrhel also has his Masters in Public Health from Harvard School of Public Health. He is an associate professor of surgery at Harvard Medical School. He is also a staff researcher at the Channing Laboratory at Brigham and Women's Hospital and holds an appointment at the MGH Institute for Heart, Vascular and Stroke Care, where he is a founding member of the Pulmonary Embolism Response Team (PERT). Dr. Kabrhel has been invited to lecture nationally and internationally on the topic of venous thromboembolic disease and teaches research methodology to emergency medicine residents. In 2002 he co-founded the HAEMR Research Interest Group (RIG) and is currently the faculty liaison to this group. The purpose of the RIG is to provide a forum for collaboration and didactic education to residents interested in clinical research. Dr. Kabrhel is core faculty for HAEMR journal club and a Harvard College summer course focused on technology and innovation.
Richard Marler, Ph.D Dr Marlar is Professor of Pathology at the University of Oklahoma. He serves as the Chief of Clinical Pathology at the Oklahoma City VA Medical Center. He has directed Coagulation Laboratories for 30 years including currently the Coagulation Labs at the University of Oklahoma Medical Center and the Routine and Special Coagulation Laboratories at the Oklahoma City VA. In addition he oversees the Molecular Diagnostics Laboratory at the Oklahoma City VA. He received his PhD from Wayne State University in Biochemistry and Physiology and did a Hemostasis Fellowship at the Scripps Clinic and Research Foundation. He serves on numerous national and international clinical coagulation committees including: CLSI Committee on Coagulation, Director of External Quality Assurance for the North American Special Coagulation Laboratory Association (NASCOLA), Co-Chairman of the ISTH Committee on Plasma Inhibitors, the International External Quality Assessment Program for Thrombosis and Hemostasis, and the CAP Coagulation Resource Committee. He is currently the Editor of the international journal Blood Coagulation and Fibrinolysis . His research focuses on the genetics of venous thrombosis and thrombophilia with special interest in protein C deficiencies. He also conducts translational research for the clinical laboratory. He is the author of over 135 articles, book chapters and monographs.
Dr. Moll received his medical degree from Freiburg University, Germany, He completed an internship/residency in internal medicine and a hematology-oncology fellowship at Duke University Medical Center (1989-1996), during which he also did a 1-year clinical coagulation fellowship at the University of North Carolina, Chapel Hill (1994-1995). Dr. Moll’s postgraduate career included a position in clinical coagulation in the cardiology division of the Humboldt University in Berlin, Germany (1997-1999). Dr. Moll has been a faculty member at UNC in the Department of Medicine and the Division of Hematology-Oncology since 1999. His clinical focus is coagulation, particularly thrombosis and thrombophilia. Dr. Moll’s research interests include clinical trials on new anticoagulants, better use of established anticoagulants, antiphospholipid antibody syndrome and postthrombotic syndrome. He has a major interest in health education of patients, public and health care providers about blood clots and clotting disorders. Since 2001 he has written a Q/A section on thrombosis and thrombophilia for the non-profit website www.fvleiden.org. Dr. Moll is a co-founder of the national patient advocacy group NBCA (National Blood Clot Alliance; www.stoptheclot.org), and a board member of the national non-profit anticoagulation provider organization AC-Forum (Anticoagulation Forum; www.acforum.org). He has authored and coauthored a number of peer-reviewed articles textbook chapters on blood clots. He is the founder of the UNC Blood Clot Education Outreach Program created in 2010.
Gabrielle earned her BSMT from the University of Wisconsin – Milwaukee. She has managed clinical laboratories ranging from small satellite laboratories to specialized laboratory sections in large metropolitan hospitals. Gabrielle worked for Poudre Valley Health System for 10 years, was a Technical Support Specialist for Diagnostica Stago for 2 years, followed by managing the hematology section at Children’s Hospital Colorado for 5 years. Gabrielle is currently the Sr. Manager of Core Laboratory Operations at Children’s Hospital Colorado. She lives in Parker, CO and enjoys spending her time with her family and 2 wire haired miniature dachshunds.
University of Wisconsin-Stevens Point
BS, Wildlife Mgmt 1987 - 1992
Suman Rathbun, MD is currently Director of the Vascular Medicine Program at OUHSC as well as director of the vascular laboratories and vascular fellowship at OU Medical Center, Oklahoma City, Oklahoma. Dr. Rathbun has been principal investigator in several research projects regarding pulmonary embolism and deep-vein thrombosis. Dr. Rathbun has published and presented both locally and nationally. She participated on the U.S. Surgeon General’s task force for awareness of deep-vein thrombosis in Washington, DC. Currently, she serves as secretary to the Society of Vascular Medicine and chair of the education committee for the Venous Disease Coalition. Suman Rathbun received her doctorate of medicine at the University of Texas at San Antonio, Texas in 1994. Dr. Rathbun received her master’s degree in epidemiology at the University of Oklahoma Health Sciences Center in 2004. She is board certified in internal medicine and vascular medicine.
Paul earned a PhD in biochemistry from Temple University in 2006, with the subject of the dissertation regarding the function of coagulation factor XI. He also did postdoctoral training in a related area before becoming a product manager and scientific affairs specialist in 2009. During his time at Stago, Paul also completed an MBA degree program at Cornell University in 2014. He has spoken to dozens of medical technologist, clinical laboratory scientist, pharmacist and clinician audiences about various topics within hemostasis and coagulation. He also has a great interest in working with clinical pathologists, pharmacists, basic scientists, and pharmaceutical researchers to perform studies and publish, contributing to advancement of the hemostasis and coagulation science.
Dr. Vandiver joined the University of Wyoming School of Pharmacy in July 2012 as a Clinical Assistant Professor of Pharmacy Practice. Upon graduating from the University of Colorado Health Sciences Center with a Doctor of Pharmacy in 2010, he completed a PGY1 pharmacy practice residency at Exempla Saint Joseph Hospital, located in Denver, Colorado. Dr. Vandiver then went on to complete a PGY2 internal medicine specialty residency, also at Exempla Saint Joseph Hospital. He is a Board Certified Pharmacotherapy Specialist. His current practice site is at Swedish Medical Center in Englewood, Colorado, practicing as an inpatient clinical pharmacist with the Swedish Family Medicine Residency Program. His academic interests include anticoagulation, pain management, cardiology, and transitions of care. Dr. Vandiver offers internal medicine rotations at Swedish Medical Center.
Dr. Oksana Volod is a pathologist in West Hollywood, California and is affiliated with Cedars-Sinai Medical Center. She received her medical degree from Uzhhorod National University Faculty of Medicine and has been in practice for more than 20 years. She is one of 46 doctors at Cedars-Sinai Medical Center who specialize in Pathology.
For bugs, spam, technical support or questions please email [email protected]
|Operating System||Internet Explorer||Firefox||Chrome||Safari|
|Windows 7||IE8+||FF10+||Chrome15+||Windows 8||IE10||FF10+||Chrome15+|
|Mac OS X||FF10+||Chrome15+||Safari5.1+|